Liqing Chi

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 06, 2023
Adenosine receptor A2b confers ovarian cancer survival and PARP inhibitor resistance through IL-6-STAT3 signalling.

Liqing Chi, Lin Huan, Chunyan Zhang

Pageof 1

Frequent Collaborators